Systematic review / meta-analysis / 2009
Omega-3 dietary supplements reduce cardiovascular deaths and nonfatal events in randomized trials
A systematic review evaluated 11 randomized placebo-controlled trials including 39,044 individuals followed for an average of 2.2 years. Supplementation with EPA and DHA (mean 1.8 g/day) reduced cardiovascular fatalities (OR 0.87, 95% CI 0.79-0.95), sudden deaths from cardiac causes (OR 0.87, 95% CI 0.76-0.99), total mortality (OR 0.92, 95% CI 0.85-0.99), and nonfatal vascular events (OR 0.92, 95% CI 0.85-0.99). Mortality benefits occurred predominantly in high-risk groups, and daily dose did not correlate with outcomes.
NANO COUNTERPOINT
On fish and fish oil
We keep this study as published. Here is the other evidence behind NANO's stance.
- A meta-analysis of 10 trials with 77,917 people found omega-3 supplements had no significant association with fatal or nonfatal coronary heart disease or major vascular events.Aung T, Halsey J, Kromhout D et al. Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals. JAMA cardiology, 2018. PMID 29387889
- A Cochrane review concluded that moderate- and high-quality evidence suggests more EPA and DHA has little or no effect on mortality or cardiovascular health, with earlier suggested benefits coming from trials at higher risk of bias. Low-quality evidence suggested plant omega-3 (ALA) may slightly reduce cardiovascular event risk.Abdelhamid AS, Brown TJ, Brainard JS et al. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. The Cochrane database of systematic reviews, 2018. PMID 30019766
- For people who want long-chain omega-3s without fish, a review found algae-based DHA raised blood DHA levels.Lane K, Derbyshire E, Li W et al. Bioavailability and potential uses of vegetarian sources of omega-3 fatty acids: a review of the literature. Critical reviews in food science and nutrition, 2014. PMID 24261532
- Study type
- Systematic review and meta-analysis
- Who was studied
- 39,044 patients across 11 randomized controlled trials
- What was measured
- Cardiovascular death, sudden death, nonfatal cardiovascular events, and all-cause mortality
THE PAPER
Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review.
Marik PE, Varon J. Clin Cardiol, 2009.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.